BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11058899)

  • 1. Mutation analysis of the hamartin gene using denaturing high performance liquid chromatography.
    Bénit P; Kara-Mostefa A; Berthelon M; Sengmany K; Munnich A; Bonnefont JP
    Hum Mutat; 2000 Nov; 16(5):417-21. PubMed ID: 11058899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denaturing high-performance liquid chromatography (DHPLC)-based prenatal diagnosis for tuberous sclerosis.
    Bénit P; Bonnefont JP; Kara Mostefa A; Francannet C; Munnich A; Ray PF
    Prenat Diagn; 2001 Apr; 21(4):279-83. PubMed ID: 11288117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein truncation test for screening hamartin gene mutations and report of new disease-causing mutations.
    Bénit P; Kara-Mostefa A; Hadj-Rabia S; Munnich A; Bonnefont JP
    Hum Mutat; 1999; 14(5):428-32. PubMed ID: 10533069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing mutations in samples with low-level mosaicism by collection and analysis of DHPLC fractionated heteroduplexes.
    Emmerson P; Maynard J; Jones S; Butler R; Sampson JR; Cheadle JP
    Hum Mutat; 2003 Feb; 21(2):112-5. PubMed ID: 12552557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NF1 gene analysis based on DHPLC.
    De Luca A; Buccino A; Gianni D; Mangino M; Giustini S; Richetta A; Divona L; Calvieri S; Mingarelli R; Dallapiccola B
    Hum Mutat; 2003 Feb; 21(2):171-2. PubMed ID: 12552569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blind analysis of denaturing high-performance liquid chromatography as a tool for mutation detection.
    O'Donovan MC; Oefner PJ; Roberts SC; Austin J; Hoogendoorn B; Guy C; Speight G; Upadhyaya M; Sommer SS; McGuffin P
    Genomics; 1998 Aug; 52(1):44-9. PubMed ID: 9740670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex.
    Ali M; Girimaji SC; Markandaya M; Shukla AK; Sacchidanand S; Kumar A
    Acta Neurol Scand; 2005 Jan; 111(1):54-63. PubMed ID: 15595939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular and clinical analyses of 84 patients with tuberous sclerosis complex.
    Hung CC; Su YN; Chien SC; Liou HH; Chen CC; Chen PC; Hsieh CJ; Chen CP; Lee WT; Lin WL; Lee CN
    BMC Med Genet; 2006 Sep; 7():72. PubMed ID: 16981987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles.
    Colosimo A; Guida V; De Luca A; Cappabianca MP; Bianco I; Palka G; Dallapiccola B
    Hum Mutat; 2002 Mar; 19(3):287-95. PubMed ID: 11857746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene.
    Roberts PS; Jozwiak S; Kwiatkowski DJ; Dabora SL
    J Biochem Biophys Methods; 2001 Jan; 47(1-2):33-7. PubMed ID: 11179759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of TSC1 and TSC2 in Korean patients with tuberous sclerosis complex.
    Choi JE; Chae JH; Hwang YS; Kim KJ
    Brain Dev; 2006 Aug; 28(7):440-6. PubMed ID: 16554133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of alpha-galactosidase a mutations causing Fabry disease by denaturing high performance liquid chromatography.
    Shabbeer J; Robinson M; Desnick RJ
    Hum Mutat; 2005 Mar; 25(3):299-305. PubMed ID: 15712228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of denaturing high performance liquid chromatography for the mutational analysis of the MEN1 gene.
    Crépin M; Pigny P; Escande F; Bauters CC; Calender A; Lefevre S; Buisine MP; Porchet N; Odou MF
    J Mol Endocrinol; 2006 Apr; 36(2):369-76. PubMed ID: 16595707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation screen of the TSC1 gene reveals 26 protein truncating mutations and 1 splice site mutation in a panel of 79 tuberous sclerosis patients.
    Young JM; Burley MW; Jeremiah SJ; Jeganathan D; Ekong R; Osborne JP; Povey S
    Ann Hum Genet; 1998 May; 62(Pt 3):203-13. PubMed ID: 9803264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A versatile denaturing HPLC approach for human beta-globin gene mutation screening.
    Bournazos SN; Tserga A; Patrinos GP; Papadakis MN
    Am J Hematol; 2007 Feb; 82(2):168-70. PubMed ID: 16924651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced detection of TP53 mutations using a GC-clamp in denaturing high performance liquid chromatography.
    Greiner TC
    Diagn Mol Pathol; 2007 Mar; 16(1):32-7. PubMed ID: 17471156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Focal cortical dysplasia of Taylor's balloon cell type: mutational analysis of the TSC1 gene indicates a pathogenic relationship to tuberous sclerosis.
    Becker AJ; Urbach H; Scheffler B; Baden T; Normann S; Lahl R; Pannek HW; Tuxhorn I; Elger CE; Schramm J; Wiestler OD; Blümcke I
    Ann Neurol; 2002 Jul; 52(1):29-37. PubMed ID: 12112044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low level mosaicism detectable by DHPLC but not by direct sequencing.
    Jones AC; Sampson JR; Cheadle JP
    Hum Mutat; 2001 Mar; 17(3):233-4. PubMed ID: 11241845
    [No Abstract]   [Full Text] [Related]  

  • 20. A high-throughput denaturing high-performance liquid chromatography method for the identification of variant alleles associated with dihydropyrimidine dehydrogenase deficiency.
    Ezzeldin H; Okamoto Y; Johnson MR; Diasio RB
    Anal Biochem; 2002 Jul; 306(1):63-73. PubMed ID: 12069415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.